The relevance of CD37 in tumor suppression has been recently shown in CD37−/− mice that spontaneously develop B-cell lymphoma, and in patients with CD37-negative B-cell lymphoma that have poor survival (45, 49). The gene discussed is CD37; the disease is neoplasm.